Caris Life Sciences, Inc. (CAI)

CIK 2019410 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Caris Life Sciences, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G/A0000315066-26-002724
Nov 4, 202610-Q0002019410-26-000069
Nov 4, 20268-K0002019410-26-000067
Sep 23, 202640002071923-26-000007
Sep 22, 20261440001950047-26-009733
Sep 17, 20261440001950047-26-009640
Sep 17, 202640002071959-26-000008
Sep 14, 20268-K0002019410-26-000061
Sep 4, 202640002071953-26-000007
Sep 4, 20261440001950047-26-009157
Sep 3, 20261440001950047-26-009094
Aug 24, 20261440001950047-26-008599
Aug 14, 202640001239690-26-000005
Aug 14, 202640001239594-26-000008
Aug 14, 202640001705850-26-000025
Aug 14, 202640001724161-26-000008
Aug 14, 202640001189394-26-000008
Aug 14, 202640002071948-26-000005
Aug 14, 202640001189395-26-000002
Aug 14, 202640002038687-26-000007
Aug 12, 2026SCHEDULE 13G/A0000905148-26-003576
Aug 7, 2026SCHEDULE 13G/A0001193125-26-340353
Aug 7, 20261440001950047-26-007834
Aug 5, 202610-Q0002019410-26-000055
Aug 5, 20268-K0002019410-26-000053